Live Breaking News & Updates on Fosun pharma

Stay informed with the latest breaking news from Fosun pharma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Fosun pharma and stay connected to the pulse of your community


acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

China , Fosun-pharma , Fosun-tourism-group , Citi-research , Goldman-sachs , Asset-management-division , Fosun-international , Club-med , Acn-newswire ,

Citi, UBS, GS view positive on Fosun's core business-focused strategy – IT Business Net

Citi, UBS, GS view positive on Fosun's core business-focused strategy – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

China , Fosun-pharma , Citi-research , Goldman-sachs , Fosun-international , Asset-management-division , Fosun-tourism-group , Club-med ,

Citi, UBS, GS view positive on Fosun's core business-focused strategy

Citi, UBS, GS view positive on Fosun's core business-focused strategy
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

China , Fosun-pharma , Fosun-tourism-group , Asset-management-division , Goldman-sachs , Fosun-international , Citi-research , Club-med ,

Fosun International On Cusp Of New 'Asset-Light' Era With Latest Sale - Fosun International (OTC:FOSUF)

Key Takeaways: Fosun International’s total debt-to-capitalization ratio stood at 50.4% at the end of last year, down 2.9 percentage points from the previous year The company recently announced the sale of most of its stake in Belgian insurer Ageas, and has raised 57.3 billion yuan from similar asset sales over the past two years

Shanghai , China , France , Belgium , Nanjing , Jiangsu , Hong-kong , Shenzhen , Guangdong , Hainan , French , Belgian

BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024

MAINZ, Germany, April 22, 2024 -- BioNTech SE will announce its financial results for the first quarter 2024 on Monday, May 6, 2024. Additionally, the Company will host a conference call and...

Germany , Fosun-pharma , Roche-group , Genentech , Pfizer , Investor-relations , New-technologies , Markets ,

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024

Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., April 18, 2024 -- Ardelyx, Inc. , a biopharmaceutical company founded with a mission to discover, develop and commercialize...

Japan , Canada , United-states , China , Fosun-pharma , Caitlin-lowie , Linkedin , Nasdaq , Twitter , Facebook , Ardelyx-inc , New-drug-application

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

/PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating, constipation, and diarrhea. Misunderstood and...

United-states , Japan , Toronto , Ontario , Canada , China , Jeffrey-roberts , Fosun-pharma , Ardelyx-inc , Patient-support-group , Irritable-bowel , Lead-partner

Gland Pharma shares in focus amid block deal reports; check details here

The two selling entities- Nicomac Machinery and RP Advisory Services- are connected to Dr Ravi Penmetsa, who is the former promoter of Gland Pharma.



China , Fosun-pharma , Ravi-penmetsa , Rp-advisory-services , Gland-pharma ,

gland pharma shares: Two entities sell 4.9 pc stake in Gland Pharma for Rs 1,411 cr

​ Two entities -- Lakumi Trust and Nicomac Machinery -- on Tuesday divested a 4.9 per cent stake in Gland Pharma for Rs 1,411 crore through open market transactions. Lakumi Trust and Nicomac Machinery Pvt Ltd disposed of 81.20 lakh shares of Gland Pharma in separate bulk deals on the National Stock Exchange (NSE).

China , Fosun-pharma , National-stock-exchange , Nicomac-machinery-pvt-ltd , Gland-pharma , Lakumi-trust , Nicomac-machinery , Gland-pharma-shares , Trust , Shares , Bulk-deal , Open